Specificity of TGF-β1 signal designated by LRRC33 and integrin αVβ8. 2022

Zelin Duan, and Xuezhen Lin, and Lixia Wang, and Qiuxin Zhen, and Yuefeng Jiang, and Chuxin Chen, and Jing Yang, and Chia-Hsueh Lee, and Yan Qin, and Ying Li, and Bo Zhao, and Jianchuan Wang, and Zhe Zhang
State Key Laboratory of Membrane Biology, Center for Life Sciences, School of Life Sciences, Peking University, 100871, Beijing, China.

Myeloid lineage cells present the latent form of transforming growth factor-β1 (L-TGF-β1) to the membrane using an anchor protein LRRC33. Integrin αVβ8 activates extracellular L-TGF-β1 to trigger the downstream signaling functions. However, the mechanism designating the specificity of TGF-β1 presentation and activation remains incompletely understood. Here, we report cryo-EM structures of human L-TGF-β1/LRRC33 and integrin αVβ8/L-TGF-β1 complexes. Combined with biochemical and cell-based analyses, we demonstrate that LRRC33 only presents L-TGF-β1 but not the -β2 or -β3 isoforms due to difference of key residues on the growth factor domains. Moreover, we reveal a 2:2 binding mode of integrin αVβ8 and L-TGF-β1, which shows higher avidity and more efficient L-TGF-β1 activation than previously reported 1:2 binding mode. We also uncover that the disulfide-linked loop of the integrin subunit β8 determines its exquisite affinity to L-TGF-β1. Together, our findings provide important insights into the specificity of TGF-β1 signaling achieved by LRRC33 and integrin αVβ8.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D016023 Integrins A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors (RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation. Integrin
D053773 Transforming Growth Factor beta1 A subtype of transforming growth factor beta that is synthesized by a wide variety of cells. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta 1 and TGF-beta1 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor. Defects in the gene that encodes TGF-beta1 are the cause of CAMURATI-ENGELMANN SYNDROME. TGF-beta1,Transforming Growth Factor-beta1,TGF-beta-1,TGF-beta1 Latency-Associated Protein,TGF-beta1LAP,Transforming Growth Factor beta 1 Latency Associated Peptide,Transforming Growth Factor beta I,Latency-Associated Protein, TGF-beta1,TGF beta 1,TGF beta1 Latency Associated Protein,TGF beta1LAP
D053779 Latent TGF-beta Binding Proteins A family of secreted multidomain proteins that were originally identified by their association with the latent form of TRANSFORMING GROWTH FACTORS. They interact with a variety of EXTRACELLULAR MATRIX PROTEINS and may play a role in the regulation of TGB-beta bioavailability. Latent TGF-beta Binding Protein,Latent TGF-beta Binding Protein 1,Latent TGF-beta Binding Protein 2,Latent TGF-beta Binding Protein 3,Latent TGF-beta Binding Protein 4,Latent TGF beta Binding Protein,Latent TGF beta Binding Protein 1,Latent TGF beta Binding Protein 2,Latent TGF beta Binding Protein 3,Latent TGF beta Binding Protein 4,Latent TGF beta Binding Proteins
D039564 Integrin alphaV An alpha integrin with a molecular weight of 160-kDa that is found in a variety of cell types. It undergoes posttranslational cleavage into a heavy and a light chain that are connected by disulfide bonds. Integrin alphaV can combine with several different beta subunits to form heterodimers that generally bind to RGD sequence-containing extracellular matrix proteins. Antigens, CD51,CD51 Antigens,CD51 Antigen,Integrin alpha V,alpha(V) Integrin,alphav Integrin,Antigen, CD51,Integrin, alphav,alpha V, Integrin,alphaV, Integrin

Related Publications

Zelin Duan, and Xuezhen Lin, and Lixia Wang, and Qiuxin Zhen, and Yuefeng Jiang, and Chuxin Chen, and Jing Yang, and Chia-Hsueh Lee, and Yan Qin, and Ying Li, and Bo Zhao, and Jianchuan Wang, and Zhe Zhang
May 2017, Proceedings of the National Academy of Sciences of the United States of America,
Zelin Duan, and Xuezhen Lin, and Lixia Wang, and Qiuxin Zhen, and Yuefeng Jiang, and Chuxin Chen, and Jing Yang, and Chia-Hsueh Lee, and Yan Qin, and Ying Li, and Bo Zhao, and Jianchuan Wang, and Zhe Zhang
April 2022, Bio-protocol,
Zelin Duan, and Xuezhen Lin, and Lixia Wang, and Qiuxin Zhen, and Yuefeng Jiang, and Chuxin Chen, and Jing Yang, and Chia-Hsueh Lee, and Yan Qin, and Ying Li, and Bo Zhao, and Jianchuan Wang, and Zhe Zhang
June 2018, Oncotarget,
Zelin Duan, and Xuezhen Lin, and Lixia Wang, and Qiuxin Zhen, and Yuefeng Jiang, and Chuxin Chen, and Jing Yang, and Chia-Hsueh Lee, and Yan Qin, and Ying Li, and Bo Zhao, and Jianchuan Wang, and Zhe Zhang
May 2016, The Journal of biological chemistry,
Zelin Duan, and Xuezhen Lin, and Lixia Wang, and Qiuxin Zhen, and Yuefeng Jiang, and Chuxin Chen, and Jing Yang, and Chia-Hsueh Lee, and Yan Qin, and Ying Li, and Bo Zhao, and Jianchuan Wang, and Zhe Zhang
January 2020, Journal of Cancer,
Zelin Duan, and Xuezhen Lin, and Lixia Wang, and Qiuxin Zhen, and Yuefeng Jiang, and Chuxin Chen, and Jing Yang, and Chia-Hsueh Lee, and Yan Qin, and Ying Li, and Bo Zhao, and Jianchuan Wang, and Zhe Zhang
February 2011, The American journal of pathology,
Zelin Duan, and Xuezhen Lin, and Lixia Wang, and Qiuxin Zhen, and Yuefeng Jiang, and Chuxin Chen, and Jing Yang, and Chia-Hsueh Lee, and Yan Qin, and Ying Li, and Bo Zhao, and Jianchuan Wang, and Zhe Zhang
February 2011, The American journal of pathology,
Zelin Duan, and Xuezhen Lin, and Lixia Wang, and Qiuxin Zhen, and Yuefeng Jiang, and Chuxin Chen, and Jing Yang, and Chia-Hsueh Lee, and Yan Qin, and Ying Li, and Bo Zhao, and Jianchuan Wang, and Zhe Zhang
October 2018, JCI insight,
Zelin Duan, and Xuezhen Lin, and Lixia Wang, and Qiuxin Zhen, and Yuefeng Jiang, and Chuxin Chen, and Jing Yang, and Chia-Hsueh Lee, and Yan Qin, and Ying Li, and Bo Zhao, and Jianchuan Wang, and Zhe Zhang
January 2015, PloS one,
Zelin Duan, and Xuezhen Lin, and Lixia Wang, and Qiuxin Zhen, and Yuefeng Jiang, and Chuxin Chen, and Jing Yang, and Chia-Hsueh Lee, and Yan Qin, and Ying Li, and Bo Zhao, and Jianchuan Wang, and Zhe Zhang
October 2021, Nature communications,
Copied contents to your clipboard!